Endometriosis occurs when estrogen-sensitive endometrial cells that are shed to distal sites manage to attach and survive in a foreign, inflammatory environment. A new study reports a unique interaction between a cleaved form of steroid receptor coactivator 1 (SRC-1) and caspase 8 that blocks apoptosis in endometriotic cells, allowing them to survive (pages 1102-1111).
NKT cell numbers, activity or both is linked to chronic viral hepatitis. Moreover, NKT cells may be a good target for immunotherapy. In support of this, activation of type 1 NKT cells can eliminate HBV 11 and enhance adaptive T cell immunity to HBsAg in mice 11, 12 . Although a clinical trial in which patients chronically infected with HBV were treated with systemic intravenous injection of the type 1 NKT cell antigen, α-GalCer, failed to show significant protective effect 13 , more targeted strategies such as combining α-GalCer with HBV vaccines should be considered for further testing. This approach has proven to be very powerful in mouse models of virus infection 14 . A caveat that should be considered with NKT cell-based immunotherapy is the potential risk that an aggressive inflammatory immune response in the liver of patients with HBV may trigger fulminant hepatic failure. The use of antigens such as lysoPE to specifically target type 2 NKT cells may also prove to be a safer approach to NKT cell-based immunotherapy.
NKT cells can control the character and vigor of immune responses. They therefore provide a valuable target for modulation of immunity to HBV and other infections. This study, together with those describing NKT cell activation by β-glucosylceramide in bacterial infections 8 , introduces a new paradigm of immune modulation in which self-lipid antigens serve as endogenous 'danger' signals by binding to CD1d and activating NKT cells.
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small implants on peritoneal surfaces, suggesting that enhanced cell survival rather than unchecked proliferation is the key biological property of endometriotic cells. Consistent with this, endometriotic cells are highly resistant to apoptosis and survive in an inflammatory environment where cytokines such as tumor necrosis factor (TNF) would prompt apoptosis in normal endometrial cells 5 . It is in this context that a study in this issue of Nature Medicine by Han et al. 6 addresses a fundamental question in endometriosis: what molecular event links aberrant TNF action and steroid signaling to prolonged cell survival?
To address this question, the authors investigated how the steroid receptor coactivators (SRCs) affect endometriosis, given that they mediate the effects of steroid hormone receptors such as the estrogen receptor and that estrogen signaling fuels this disease. By comparing mouse models and human samples of endometriosis, Han et al. 6 deduced that SRC-1 expression was crucial for disease progression, but the amounts of SRC-1 protein at its expected molecular weight were unexpectedly reduced in the diseased cells. Furthermore, their mouse model showed similar expression of the SRC-1 mRNA in both healthy and diseased tissues.
Endometriosis afflicts millions of women worldwide causing severe menstrual pain, chronic pelvic pain and infertility during what should be their peak years of health 1 . Menstruation is the key trigger for this disease, and although uninterrupted menstrual cycles seem to increase the risk for the endometriosis, it is not understood why only a subset of women develop the disease. When we have asked our patients with endometriosis about menstruation-related symptoms during their teenage years, the vast majority reported debilitating menstrual cramps when they were teenagers that worsened during the following years-thus the disease's symptoms seem to manifest almost immediately after menarche. This consistent feature of endometriosis suggests that these women were predisposed to developing endometriosis from early on in life.
Like menstruation, endometriosis occurs exclusively in primates 2 , suggesting that our understanding of this disease's etiology is stunted by the older question of what evolutionary burden drove primates to menstruate when other mammals do not. In placental mammals, sex steroids and cytokines remodel the endometrium to provide a controlled environment that protects and nourishes the embryo while tempering the maternal immuno logical and inflammatory responses against the embryo itself. Primates uniquely initiate this process before conception, as the periodic shedding and regeneration of endometrial tissue is prerequisite for the deep placental invasion of its stroma and blood vessels. But repetitive menstruation also has an undesired side effect: the retrograde flushing of endometrial tissue and blood onto the pelvic peritoneum, which was proposed by Sampson over 90 years ago to drive the pathogenesis of endometriosis 3 . This theory has upheld well, and currently the definitive method for diagnosing endo metriosis is the laproscopic detection of endometrium-like tissue at inflamed ectopic sites, mostly in the pelvic peritoneal cavity 4 . Importantly, these transplanted cells are characterized by molecular and epigenetic defects that allow them to survive in response to estrogen outside the uterus 2 .
In most women with endometriosis and pelvic pain, the disease is limited to sparse, endometriosis harbor a larger population of these disease-predisposing cells.
The findings of Han et al. 6 provide new insights into how the TNF pathway is conscripted to enhance endometriotic cell survival, but they leave researchers with several questions. Principally, how widespread is this phenomenon regarding the other SRC members and with respect to other tissues? The TNF-MMP9-SRC-1 signaling axis is likely to function in tissues where steroid signaling and inflammation are present and could potentially block apoptosis in cancers in which progression is also correlated with TNF and MMP expression. This pathway may be particularly important in breast cancer, where tumors expressing SRC-1 possess a more aggressive and dedifferentiated phenotype 11 . Regarding the proteolysis of the SRC family members, the MMP9 cleavage site of SRC-1 is well conserved from mice to humans, and Han et al. 6 note that SRC-2 and SRC-3 might be similarly processed. O'Malley and others have firmly established that SRCs function as 'pleiotropic rheostats' that coordinate nuclear receptor activity 12 ; however, similar mechanisms for the other SRCs would be groundbreaking, expanding the role of SRCs into truly multifunctional proteins. It is now vital to explore how truncated SRC isoforms affect nuclear receptor function and distribution, especially given the cytoplasmic localization of the shorter isoform observed by Han et al. 6 . The expression of estrogen and progesterone receptors are profoundly altered in endometriosis, and the redistribution of SRC isoforms with respect to their binding across the genome or their functions in the cytoplasm could affect the sensitivity of diseased tissues to steroid hormones.
The potential treatment options for endometriosis that the discovery of the TNF-MMP9-SRC-1 axis points toward are equally exciting. Recently, TNF inhibitors (infliximab and etanercept) have been used to treat endometriosis in nonhuman primate and rodent models, suggesting that focused work in this area will be fruitful 13 . Similarly, MMP9 inhibitors currently being developed to treat invasive cancer 14 may also prove effective for endometriosis. Han et al. 6 suggest that the cleaved SRC-1 isoform is unique to endometriosis, raising the possibility that the detection of the short SRC-1 isoform could be used in endometriosis diagnosis. Looking ahead, the treatment options for endo metriosis could improve as the TNF-MMP9-SRC-1 pathway is further dissected, but more importantly the work presented here sheds important light on how some of the therapies currently in testing operate and new insights for how to improve them.
The most attractive of these is MMP9, which along with upstream MMPs and regulatory tissue inhibitors (TIMPs) is crucial for remodeling the endometrium in response to steroid hormones both before and during implantation 7 . In the endometrium, steroid hormones and epigenetic mechanisms coordinate the expression of the MMPs and TIMPs during development and during each menstrual cycle 7, 8 . Moreover, aberrant DNA methylation of the genes encoding these proteins has been associated with disease, and hypomethylation of the genes encoding MMPs occurs frequently in cancers, where their increased expression enhances tumor progression and invasion 9 . Epigenetic defects and increased estrogen in endometrial cells that trigger MMP activity could jumpstart the proteolysis of SRC-1, thereby creating more effective seeds for endometriosis. It is striking that in rodent and nonhuman primate models, if a sufficient amount of endometrial tissue is transplanted to the peritoneum, endometriosis can develop, despite these models having low or absent levels of spontaneous endometriosis 10 . This suggests that a small population of endometrial cells is predisposed to causing the disease and that perhaps women prone to These observations were explained when the authors found that SRC-1 can be proteolytically cleaved in diseased cells by matrix metalloproteinase-9 (MMP9) into a previously unknown shorter SRC-1 isoform, which distributes to the cytoplasm as well as the nucleus. Remarkably, the short isoform retained its ability to interact with nuclear receptors but could also bind and inhibit procaspase-8, thereby blocking apoptosis (Fig. 1) . More importantly, the authors found that the SRC-1 cleavage process is activated by TNF 6 . Thus, endometriotic cells can survive TNF-induced apoptosis more effectively than healthy cells by processing SRC-1 into a shorter isoform that blocks the execution phase of apoptosis.
The characterization of a TNF-MMP9-SRC-1 axis in endometriosis by Han et al. 6 mechanistically connects well-established markers of endometriosis with the progression of the disease, but what initiates this axis is unknown. The heritable component of endometriosis is likely to be epigenetic 2 , and the members of this newly identified TNF-MMP9-SRC-1 pathway provide a targeted list of candidates for an epigenetically mediated mechanism of endometriosis pathogenesis.
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Figure 1 SRC-1 in the etiology of endometriosis. Menstruation follows the withdrawal of steroid hormones ending the luteal phase, during which time endometrial tissue is often unintentionally shed into the pelvic peritoneum. Most of these endometrial cells apoptose; however, defects (either pre-existing or acquired) in some cells can alter the expression of key genes affecting steroid signaling and the TNF response that predisposes them to driving endometriosis. Han et al. 6 now show that in endometriosis TNF-activated MMP9 cleaves SRC-1 to generate a truncated SRC-1 isoform, which is distributed to the nucleus and cytoplasm. The truncated SRC-1 retains its ability to interact with nuclear receptors, but it can also bind procaspase-8, potently blocking the ability of TNF and other signals to induce apoptosis. ADAM, a disintegrin and metalloproteinase; CCL5, chemokine (C-C motif) ligand 5; ERα, estrogen receptor-α; HOXA10, homeobox A10; IL-1β, interleukin-1β; NK, natural killer; PGE 2 , prostaglandin E 2 ; PR, progesterone receptor; SF-1, steroidogenic factor 1. 
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Although the IL-23 pathway has been implicated in the pathogenesis of spondyloarthritis, it was previously unclear how it promotes enthesitis. In this issue of Nature Medicine, Sherlock et al. 7 identify a previously undescribed lineage of T cells in the enthesis that is responsive to IL-23. They then show that IL-23-mediated stimulation of these lymphocytes leads to the development of entheseal inflammation and local bone remodeling in a mouse model (Fig. 1) . This work provides an elegant and intriguing cellular link between tissue-specific pathology and systemic cytokine First recognized in ancient Egypt, few musculoskeletal diseases have as notable a phenotype as the postural deficit arising from advanced ankylosing spondylitis. Formerly known as Bechterew's disease, ankylosing spondy litis is the prototypic and most common form of spondyloarthritis. Spondyloarthritis has a prevalence of 1-2% worldwide (affecting 2.4 million people in the United States alone) and causes high levels of disability and a reduced quality of life in those afflicted, as well as a substantial socioeconomic burden 1 .
Despite the recognition of an association between the human leukocyte antigen B27 (HLA-B27) and this disease over three decades ago, our understanding of the pathogenesis of ankylosing spondylitis is remarkably limited. The factors that initiate disease processes, the reason why specific sites in the skeleton are affected and the complex relationship between inflammation and new tissue formation have been extensively studied but are still not well defined. Recent genome-wide studies in people with ankylosing spondylitis have identified several disease-associated loci, particularly the IL-23 receptor (IL-23R) 2 . This receptor is of particular interest because it has also previously been associated with other spondyloarthritisassociated dis orders such as Crohn's disease and psoriasis 3, 4 .
Ankylosing spondylitis comprises inflammation and progressive ankylosis of sacroiliac joints and the spine and is frequently accompanied by oligoarthritis and inflammation of the enthesis, the anatomical zone in which tendons and ligaments insert into bone (enthesitis). Extra-articular features of the disease include involvement of the eye (uveitis) and, more rarely, cardiac structures. Elegant imaging and comparative anatomy studies have suggested that the enthesis may actually be the initiating site for musculoskeletal inflammation in ankylosing spondylitis 5, 6 , although in established disease, enthesitis is typically accompanied by synovitis and osteitis. The enthesis is a layered anatomical interface formed by tendon fibers, uncalcified fibrocartilage, mineralized
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The enthesis is the region at the junction between tendon and bone and has been suggested to be a key target in spondyloarthritic diseases. This zone is now shown to contain a unique population of resident T cells, which, when activated by the cytokine interleukin-23 (IL-23), can promote pathogenesis that is characteristic of spondyloarthritis (pages 1069-1076). 
